Why Cantor's Mara Goldstein Just Downgraded ImmunoGen

By: via Benzinga
In a report published Monday, Cantor Fitzgerald analyst Mara Goldstein downgraded the rating on ImmunoGen, Inc. (NASDAQ: IMGN) from Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.